US 10975043
Heterocyclic compound
granted A61KA61K31/415A61K31/421
Quick answer
US patent 10975043 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Apr 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K31/415, A61K31/421, A61K31/4418, A61K31/505